Abstract
In non-inferiority (NI) trials with time-to-event data, different types and patterns of censoring may occur, but their impact on trial results is not entirely clear. We investigated the influence of informative and non-informative censoring by conducting extensive simulation studies under the assumption that the NI margin is defined as a maximum acceptable hazard ratio and scenarios typically observed in recent NI trials. We found that while non-informative censoring tends to only affect the power, informative censoring can impact the treatment effect estimates, type I error rate, and power. The magnitude of these effects depends on the between-group differences in the failure and informative censoring risks, as well as the correlation between censoring and failure times, among other factors. The adverse impact of informative censoring was generally decreased with larger NI margins.
Original language | English (US) |
---|---|
Pages (from-to) | 222-239 |
Number of pages | 18 |
Journal | Journal of Biopharmaceutical Statistics |
Volume | 34 |
Issue number | 2 |
DOIs | |
State | Published - 2024 |
Keywords
- Cox proportional hazards model
- Non-inferiority trials
- informative censoring
- time-to-event data
ASJC Scopus subject areas
- Statistics and Probability
- Pharmacology
- Pharmacology (medical)